Hong Kong Pharmaceuticals & Biotech Undervalued Small Caps

Consun Pharmaceutical Group

Market Cap: HK$7.9b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Shanghai Haohai Biological Technology

Market Cap: HK$11.5b

Shanghai Haohai Biological Technology Co., Ltd.

Essex Bio-Technology

Market Cap: HK$2.5b

An investment holding company, develops, manufactures, and sells biologic drugs in the People’s Republic of China, Hong Kong, and internationally.

Viva Biotech Holdings

Market Cap: HK$3.0b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.